This page is translated by Google and can contain errors. Go back to English.

News

Guide on non-conventional treatment options in breast cancer

ReDO: propranolol as an anti-cancer agent

Pantziarka, P., Bouche, G., Sukhatme, V., Meheus, L., Rooman, I., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agent. Ecancermedicalscience, 10, 680. doi:10.3332/ecancer.2016.680

ReDO: diclofenac as an anti-cancer agent

Pantziarka, P., Sukhatme, V., Bouche, G., Meheus, L., & Sukhatme, V. P. (2016). Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. Ecancermedicalscience, 10, 610. doi:10.3332/ecancer.2016.610

Patient and health systems opportunities

Bertolini, F., Sukhatme, V.P., & Bouche, G. (2015). Drug repurposing in oncology—patient and health systems opportunities. Nature Reviews Clinical Oncology, 12(12):732-42. doi:10.1038/nrclinonc.2015.169

ReDO: nitroglycerin as an anti-cancer agent

Sukhatme, V., Bouche, G., Meheus, L., Sukhatme, V. P., & Pantziarka, P. (2015). Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent. Ecancermedicalscience, 9, 568. doi:10.3332/ecancer.2015.568

Therapeutic effect of Cryoablation and Meriva in Breast Cancer

Chandra, D., Jahangir, A., Cornelis, F., Rombauts, K., Meheus, L., Jorcyk, C. L., & Gravekamp, C. (2015). Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer. Oncoimmunology, 5(1), e1049802. doi:10.1080/2162402X.2015.1049802